Atlas Trials

Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis

Clinical trial NCT05329090 · COMPLETED

Trial details

NCT number
NCT05329090
Sponsor
Hopital Foch
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
IgA Vasculitis
Start date
2022-03-11
Primary completion
2026-01-13
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.